Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Why Dr. Oz's Family Won't Take the Swine Flu Vaccine 3:40 AM
11/12/2009
Alternative Health Journal
Dr. Mehmet Oz is arguably the
best-known doctor in the US. It's reported his wife and four children will not be receiving the swine flu
vaccine to escape the potential health hazard.
...
Biogen
Rethinking Disclosure Policies On MS Drug Tysabri 5:57 PM 11/11/2009
Wall Street Journal
The number of cases of progressive multifocal
leukoencephalopathy (PML) jumped to 24 in patients taking the multiple sclerosis treatment Tysabri sold by
Biogen Idec Inc and Elan Corp.
...
New
data to show 4000 US deaths from swine flu 3:53 PM 11/11/2009
USA Today
Up from 1200, the new estimate is a more accurate accounting of deaths directly
attributable to swine flu and other causes linked to the H1N1 virus like pneumonia, infections, and organ
failure.
...
Altus
Pharmaceuticals files for bankruptcy 3:38 PM 11/11/2009
Boston Globe
Altus Pharmaceuticals Inc told regulators in September it was starting the process
of shutting down its operations. It filed for bankruptcy protection under Chapter 7 of the US Bankruptcy Code
today.
...
Teva
Wins Ruling Over Copy of Takeda's Prevacid Drug 6:05 PM 11/10/2009
Bloomberg
Teva Pharmaceutical Industries won a US court ruling that may let it
sell a generic of Takeda Pharmaceutical Co’s heartburn drug Prevacid SoluTab.
...
Regeneron, Sanofi,
expand drug partnership 3:34 PM 11/10/2009
Reuters
Regeneron Pharmaceuticals Inc
and Sanofi-aventis have expanded their partnership to develop a
number of Regeneron's experimental drugs.
...
Study
confirms clot risks with anti-anemia drugs 2:54 PM 11/10/2009
Reuters
Cancer patients who took erythropoiesis-stimulating agents (ESAs) to cut
the risk of anemia were twice as likely to develop blood clots in the lungs or legs.
...
Drugmakers
don't see major US reform boost 3:27 PM 11/10/2009
Reuters
Manufacturers have pledged to contribute $80 billion over a decade to help pay for an
expansion of health insurance. There is no obvious upside with impact depending on final details.
...
Bristol-Myers
buys rights to RA drug $85 million 6:07 AM 11/10/2009
Reuters
Bristol-Myers Squibb agreed to buy rights to an experimental rheumatoid arthritis drug
being developed by privately held biotechnolgy company Alder Biopharmaceuticals Inc.
...
Ironwood
unveils Japanese licensing agreement 5:26 AM 11/10/2009
Boston Globe
Ironwood Pharmaceuticals Inc said Astellas Pharma Inc will pay it $75 million in
upfront and pre-commercial milestone payments for the exclusive rights to develop and commercialize linaclotide
in some Asian markets.
...
Who
needs two doses of vaccine? 3:57 AM 11/10/2009
Washington Post
The US recommendation is that you need two doses of 2009 H1N1 vaccine about
four weeks apart if you are under 9 using same type as the first dose.
...
Health
companies see relief in US Senate bill 12:35 PM 11/9/2009
Reuters
Insurers, drugmakers, and other health-related companies expect US Senate lawmakers to
soften the blow from health reform legislation.
...
Enzon
Agrees To Sell Specialty-Drug Business For Up To
$327M 8:54 AM 11/9/2009
Wall Street
Journal
Enzon Pharmaceuticals Inc will sell its specialty pharmaceutical business to the sigma-tau
Group adding royalties above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products
Oncaspar, Adagen, DepoCyt, and Abelcet.
...
FDA
Extends Review of XenoPort-Glaxo Pain Drug 6:13 AM 11/9/2009
ABC News
XenoPort and GlaxoSmithKline said the US FDA should complete its review
of the drug gabapentin enacarbil by February 9, 2010. The agency needs additional time to review GSK's strategy
to evaluate the drug's risks.
...
D-Pharm
strikes drug deal with Wanbang 7:41 AM 11/8/2009
Reuters
Israeli biopharmaceutical firm D-Pharm signed a deal with Wanbang Biopharmaceuticals to
jointly develop and distribute its DP-b99 stroke prevention treatment in China. DP-b99 is currently undergoing
Phase III clinical trials.
...
<- Day Earlier | Today's News
|
